Saphnelo® 300mg/2ml International English

Saphnelo® is a medicine used as an add-on treatment in adults with systemic lupus erythematosus (SLE), a disease in which the immune system (the body’s natural defences) attacks normal cells and tissues, causing inflammation and organ damage.

Saphnelo®  is given to patients who have antibodies against their own cells (autoantibodies) and whose disease is still moderate to severe despite standard treatment.

The recommended dosage of SAPHNELO is 300 mg, administered as an intravenous infusion over a 30-minute period, every 4 weeks.

Common Side Effects:

• Upper respiratory tract infections (e.g., nasopharyngitis)

• Bronchitis

• Infusion-related reactions (e.g., headache, nausea, dizziness, chills)

• Herpes zoster (shingles)

• Cough

• Rash

• Fatigue

• Headache